{"id":"NCT00846365","sponsor":"Takeda","briefTitle":"Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension","officialTitle":"A Phase 3, Double-Blind, Randomized, Efficacy and Safety Study Comparing the TAK-491 Plus Chlorthalidone Fixed-Dose Combination vs Benicar HCT® (Olmesartan Medoxomil-Hydrochlorothiazide) in Subjects With Moderate to Severe Essential Hypertension","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-03","primaryCompletion":"2010-06","completion":"2010-06","firstPosted":"2009-02-18","resultsPosted":"2012-03-13","lastUpdate":"2012-03-13"},"enrollment":1085,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Essential Hypertension"],"interventions":[{"type":"DRUG","name":"Azilsartan medoxomil and chlorthalidone","otherNames":["azilsartan medoxomil","chlorthalidone","TAK-491","TAK-491CLD"]},{"type":"DRUG","name":"Azilsartan medoxomil and chlorthalidone","otherNames":["azilsartan medoxomil","chlorthalidone","TAK-491","TAK-491CLD"]},{"type":"DRUG","name":"Olmesartan medoxomil-hydrochlorothiazide","otherNames":["Benicar HCT®"]}],"arms":[{"label":"Azilsartan Medoxomil 20-40mg plus Chlorthalidone 12.5-25 mg QD","type":"EXPERIMENTAL"},{"label":"Azilsartan Medoxomil 40-80mg plus Chlorthalidone 12.5-25 mg QD","type":"EXPERIMENTAL"},{"label":"Olmesartan medoxomil 20-40mg/hydrochlorothiazide 12.5-25mg QD","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine the efficacy and safety of azilsartan medoxomil combined with chlorthalidone, once daily (QD), in participants with moderate to severe essential hypertension.","primaryOutcome":{"measure":"Change From Baseline to Week 8 in Trough, Sitting, Clinic Systolic Blood Pressure.","timeFrame":"Baseline and Week 8.","effectByArm":[{"arm":"Azilsartan Medoxomil 20-40mg Plus Chlorthalidone 12.5-25 mg QD","deltaMin":-37.6,"sd":0.83},{"arm":"Azilsartan Medoxomil 40-80mg Plus Chlorthalidone 12.5-25 mg QD","deltaMin":-38.2,"sd":0.85},{"arm":"Olmesartan Medoxomil 20-40mg/Hydrochlorothiazide 12.5-25mg QD","deltaMin":-31.5,"sd":0.84}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":80,"countries":["United States","Chile","Mexico"]},"refs":{"pmids":["29334491"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":372},"commonTop":["Blood creatinine increased","Dizziness","Headache"]}}